Yoninah Cramer

Also affiliated with Frontier Science & Technology Research Foundation, Inc.

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial”.

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(20)30770-2

N/A

4.9DataRank · unranked

124 citations

Susan L. Rosenkranz, Francesca Conradie, Laura Moran, Richard Hafner, Florian von Groote-Bidlingmaier +26 more

Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2685

N/A

0.457DataRank · unranked

20 citations

Mats O. Karlsson, Susan L. Rosenkranz, Yoninah Cramer, Justin Shenje, Caryn M. Upton +6 more

Twice-Daily Dolutegravir–Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention

Clinical Infectious Diseases(2024)10.1093/cid/ciae183

N/A

0.372DataRank · unranked

6 citations

Yoninah Cramer, Marjorie Z. Imperial, Susan L. Rosenkranz, Anchalee Avihingsanon, Roberto C. Arduino +7 more

Novel Dosing Strategies Increase Exposures of the Potent Antituberculosis Drug Rifapentine but Are Poorly Tolerated in Healthy Volunteers

UNC Libraries(2020)10.17615/48tz-4826

N/A

0DataRank · unranked

0 citations

Evelyn Hogg, Constance A. Benson, Kristine Y. Patterson, Jennifer Janik, Richard Hafner +8 more

Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis

Pharmacogenetics and Genomics(2025)10.1097/fpc.0000000000000562

N/A

0DataRank · unranked

3 citations

Anne F. Luetkemeyer, Marjorie Z. Imperial, Rodney Dawson, Yoninah Cramer, Sue Rosenkranz +10 more